A coalition of seven top pharma companies is collaborating with the FDA on a hunt for genetic markers that may predict patients vulnerability to serious drug-related adverse events.
Pfizer is working on two next-generation delivery devices for its inhaled insulin, Exubera — disappointing sales of which have been blamed, in part, on its unwieldy design, which has drawn comparisons to that of a water bong.
A late-stage trial of Eli Lillys inhaled insulin is slated to wrap in time for the firm to submit the product in 2009, an executive said today.
Company news
September 25, 2007
4:00 am
Amgen said on Monday that 2,200 employees would lose their jobs under a company restructuring that includes about 675 layoffs at its headquarters in Thousand Oaks, CA, The Ventura County Star reported.
Product news
September 25, 2007
4:00 am
GlaxoSmithKline announced that the European Commission has granted a marketing authorization for its cervical cancer vaccine, Cervarix, for all 27 European member states.
Google yesterday sought to pour cold water on rumors that the company is looking to get into the healthcare or advertising and media services businesses.
Professional ads for Pfizers Chantix and Organons NuvaRing were the years top-rated as judged by physicians in the Association of Medical Medias fifth annual Doctors’ Choice Awards.
Pharma online ad spend on the rise but content could be faring better: report
Online ad spend by the pharmaceutical and healthcare industry will hit $975 million in 2007, a gain of 19% over 2006, according to a report unveiled this week by market research firm eMarketer.